Literature DB >> 14616345

Actinic keratosis: epidemiology and progression to squamous cell carcinoma.

M Lebwohl1.   

Abstract

Actinic keratoses are a common problem in the population, and one of the most common conditions treated by dermatologists. Risk factors for the development of actinic keratosis are those associated with increased sun exposure and increased susceptibility to sun exposure such as low latitude, working outdoors, light skin, and history of sunburn. The role of the immune system is clear from the frequency of actinic keratoses in transplant patients. There is strong evidence that actinic keratoses can progress to squamous cell carcinoma, underscoring the need to identify and treat patients at risk.

Entities:  

Mesh:

Year:  2003        PMID: 14616345     DOI: 10.1046/j.0366-077x.2003.05621.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Interventions for actinic keratoses.

Authors:  Aditya K Gupta; Maryse Paquet; Elmer Villanueva; William Brintnell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 2.  Squamous cell carcinoma of the skin (non-metastatic).

Authors:  Adèle C Green; Penelope McBride
Journal:  BMJ Clin Evid       Date:  2014-08-18

Review 3.  Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.

Authors:  Spencer M Vale; Dane Hill; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

4.  Validation of actinic keratosis diagnosis and treatment codes among veterans living with HIV.

Authors:  Krittin J Supapannachart; Chase W Kwon; Sokol Tushe; Jodie L Guest; Suephy C Chen; Howa Yeung
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-03-28       Impact factor: 2.732

5.  Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.

Authors:  Romain Neugebauer; Katherine A Su; Zheng Zhu; Monica Sokil; Mary-Margaret Chren; Gary D Friedman; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2018-11-17       Impact factor: 11.527

6.  Clinicopathological study of 21 cases of eyelid actinic keratosis.

Authors:  Elena López-Tizón; Enrique Mencía-Gutiérrez; María Garrido-Ruíz; Esperanza Gutiérrez-Díaz; Fernando López-Ríos
Journal:  Int Ophthalmol       Date:  2008-07-17       Impact factor: 2.031

7.  UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes.

Authors:  Dawn Queen; Yao Shen; Megan H Trager; Adriana T Lopez; Faramarz H Samie; Jesse M Lewin; George W Niedt; Larisa J Geskin; Liang Liu
Journal:  FASEB J       Date:  2020-08-10       Impact factor: 5.191

8.  Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders.

Authors:  Richard D Bennett; Mark R Pittelkow; Emanuel E Strehler
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

9.  A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.

Authors:  G Pellacani; K Peris; C Guillen; F Clonier; T Larsson; R Venkata; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-08-24       Impact factor: 6.166

10.  Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.

Authors:  Sara Mazzilli; Virginia Garofalo; Alessandra Ventura; Laura Diluvio; Massimo Milani; Luca Bianchi; Elena Campione
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.